- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.87 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 4 x F89: S)-2-(5(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)1-OXO-2-ISOINDOLINYL)GLUTARIC ACID(Non-covalent)
F89.2: 16 residues within 4Å:- Chain A: S.290, E.294, Y.314, I.315, W.316, N.319, L.399, D.426, L.429, G.430, F.433, Y.466, M.517, M.519, A.520
- Ligands: UMP.1
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:I.315, A:I.315, A:L.399
- Hydrogen bonds: A:S.290, A:E.294, A:Y.314, A:D.426, A:D.426, A:M.517
- pi-Stacking: A:F.433, A:F.433
F89.3: 14 residues within 4Å:- Chain A: V.9, V.10, A.11, L.25, D.32, L.33, F.36, S.37, I.62, L.67, R.70, C.113, T.134
- Ligands: NDP.4
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:A.11, A:L.25, A:L.33, A:L.33, A:F.36, A:I.62
- Hydrogen bonds: A:D.32, A:D.32
- Salt bridges: A:R.70
F89.6: 16 residues within 4Å:- Chain B: S.290, E.294, Y.314, I.315, W.316, N.319, L.399, D.426, L.429, G.430, F.433, Y.466, M.517, M.519, A.520
- Ligands: UMP.5
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:I.315, B:I.315, B:L.399
- Hydrogen bonds: B:S.290, B:E.294, B:Y.314, B:D.426, B:M.517
- pi-Stacking: B:F.433, B:F.433
F89.7: 14 residues within 4Å:- Chain B: V.9, V.10, A.11, L.25, D.32, L.33, F.36, S.37, I.62, L.67, R.70, C.113, T.134
- Ligands: NDP.8
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:A.11, B:L.25, B:L.33, B:L.33, B:F.36, B:I.62
- Hydrogen bonds: B:D.32
- Salt bridges: B:R.70
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.4: 28 residues within 4Å:- Chain A: V.10, A.11, I.19, G.20, I.21, G.23, Q.24, L.25, G.55, R.56, K.57, T.58, S.61, I.75, S.76, S.77, S.78, R.92, C.113, G.114, G.115, E.116, S.117, I.118, Y.119, D.121, T.145
- Ligands: F89.3
24 PLIP interactions:24 interactions with chain A- Hydrophobic interactions: A:L.25, A:T.58
- Hydrogen bonds: A:A.11, A:I.19, A:I.21, A:G.23, A:G.23, A:G.55, A:R.56, A:K.57, A:T.58, A:S.61, A:S.76, A:S.77, A:S.78, A:G.114, A:E.116, A:S.117, A:S.117, A:I.118, A:D.121, A:D.121, A:T.145
- Salt bridges: A:R.56
NDP.8: 28 residues within 4Å:- Chain B: V.10, A.11, I.19, G.20, I.21, G.23, Q.24, L.25, G.55, R.56, K.57, T.58, S.61, I.75, S.76, S.77, S.78, R.92, C.113, G.114, G.115, E.116, S.117, I.118, Y.119, D.121, T.145
- Ligands: F89.7
24 PLIP interactions:24 interactions with chain B- Hydrophobic interactions: B:L.25, B:T.58
- Hydrogen bonds: B:A.11, B:I.19, B:I.21, B:G.23, B:G.23, B:G.55, B:R.56, B:K.57, B:T.58, B:T.58, B:S.61, B:S.76, B:S.77, B:S.78, B:G.114, B:E.116, B:S.117, B:S.117, B:I.118, B:Y.119, B:D.121
- Salt bridges: B:R.56
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Anderson, A.C., Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance. Acta Crystallogr.,Sect.F (2005)
- Release Date
- 2004-05-18
- Peptides
- bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.87 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 4 x F89: S)-2-(5(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)1-OXO-2-ISOINDOLINYL)GLUTARIC ACID(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Anderson, A.C., Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance. Acta Crystallogr.,Sect.F (2005)
- Release Date
- 2004-05-18
- Peptides
- bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
E